2Chobanian AV,Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention,detection, evaluation, and treatment of high blood pressure [J]. Hypertension,2003,42 (6):1206-1252.
3Pitt B,Remme W,Zannad F,et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [ J ]. N Engl J Med,2003,348(14) : 1309-1321.
4Antman E M,Anbe DT,Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) [ J]. Circulation.2004. 110(5):588-636
5de Mello WC. Beneficial effect of eplerenone on cardiac remodelling and electrical properties of the failing heart[J]. J Renin Angiotensin Aldosterone Syst, 2006,7( 1 ) :40-46.
6Kobayashi N, Yoshida K, Nakano S, et al. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts [ J ]. Hypertension, 2006,47 (4) :671-679.
7Williams GH ,Burgess E, Kolloch RE, et al. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension [ J ]. Am J Cardiol, 2004,93 ( 8 ) : 990 -996.
8Hillebrand U ,Schillers H, Riethmuller C, et al. Dose-dependent endothelial cell growth and stiffening by aldosterone : endothelial protection by eplerenone[ J ]. J Hypertens, 2007,25 ( 3 ) :639-647.
9Burla AK, Neves MF,Oigman W,et al. Eplerenone offsets cardiac and aortic adverse remodeling in spontaneously hypertensive rats [ J ]. lnt J Cardiol,2007,114 (1):64-70.
10Bayorh MA, Mann G, Walton M, et al. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats [ J ]. Clin Exp Hypertens,2006,28(2) :121-132.
